We are live on
!
Find out more
HC
Henshaw Capital Portfolio holdings
AUM
$3.07B
1-Year Est. Return
40.85%
This Fund
S&P 500
This Quarter
Est. Return
-5.16%
1 Year Est. Return
+40.85%
3 Year Est. Return
+128.2%
5 Year Est. Return
+170.36%
10 Year Est. Return
+567.65%
AUM
$1.35B
AUM Growth
-$89.7M
(-6.2%)
Cap. Flow
-$1.42M
Cap. Flow
% of AUM
-0.1%
Top 10 Holdings %
Top 10 Hldgs %
33.95%
Holding
320
New
19
Increased
52
Reduced
51
Closed
26
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Xometry
XMTR
|
+$1.13M |
| 2 |
Envista
NVST
|
+$686K |
| 3 |
Booz Allen Hamilton
BAH
|
+$506K |
| 4 |
Ferrari
RACE
|
+$461K |
| 5 |
lululemon athletica
LULU
|
+$433K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Carlisle Companies
CSL
|
+$882K |
| 2 |
Sanofi
SNY
|
+$412K |
| 3 |
Colgate-Palmolive
CL
|
+$407K |
| 4 |
BJs Wholesale Club
BJ
|
+$404K |
| 5 |
Stanley Black & Decker
SWK
|
+$368K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.15% |
| 2 | Industrials | 16.05% |
| 3 | Healthcare | 12.76% |
| 4 | Financials | 11.9% |
| 5 | Consumer Discretionary | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
301
Colgate-Palmolive
CL
$72.3B
| – | – |
-5,079
| Closed | -$407K |
|
302
Capital One
COF
$132B
| – | – |
-2,695
| Closed | -$281K |
|
303
Ford
F
$55.3B
| – | – |
-12,273
| Closed | -$137K |
|
304
iShares International Select Dividend ETF
IDV
$8.6B
| – | – |
-13,127
| Closed | -$357K |
|
305
Kaiser Aluminum
KALU
$2.56B
| – | – |
-3,451
| Closed | -$273K |
|
306
Medtronic
MDT
$117B
| – | – |
-2,348
| Closed | -$211K |
|
307
Marvell Technology
MRVL
$195B
| – | – |
-5,948
| Closed | -$259K |
|
|
NSA
308
DELISTED
National Storage Affiliates Trust
NSA
| – | – |
-4,643
| Closed | -$232K |
|
309
Open Text
OTEX
$6.08B
| – | – |
-6,205
| Closed | -$235K |
|
310
Parker-Hannifin
PH
$125B
| – | – |
-1,104
| Closed | -$272K |
|
311
Prologis
PLD
$134B
| – | – |
-2,589
| Closed | -$305K |
|
312
Q2 Holdings
QTWO
$4.06B
| – | – |
-5,241
| Closed | -$202K |
|
313
Ultragenyx Pharmaceutical
RARE
$2.52B
| – | – |
-4,512
| Closed | -$269K |
|
314
Semtech
SMTC
$12.2B
| – | – |
-5,023
| Closed | -$276K |
|
315
Smith & Nephew
SNN
$12.1B
| – | – |
-8,318
| Closed | -$232K |
|
|
316
Sanofi
SNY
$107B
| – | – |
-8,228
| Closed | -$412K |
|
|
317
Stanley Black & Decker
SWK
$14.8B
| – | – |
-3,514
| Closed | -$368K |
|
318
Toyota
TM
$230B
| – | – |
-1,346
| Closed | -$208K |
|
319
Trane Technologies
TT
$98.8B
| – | – |
-1,806
| Closed | -$235K |
|
|
ABB
320
DELISTED
ABB Ltd
ABB
| – | – |
-9,632
| Closed | -$257K |
|
Similar funds
DMIC
SAM
PCM
CI
BAM
SFS
WWM
WG
Henshaw Capital's Q3 2022 Portfolio in Review
As of Q3 2022, Henshaw Capital held 320 positions worth $1.35B, down 6.2% from $1.44B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Henshaw Capital's Q3 2022 filing shows 19 new, 52 increased, 51 reduced and 26 closed positions. Its largest new stake was Ferrari: 2,310 shares worth $427K. The largest sale was Carlisle Companies, an estimated $882K.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Industrials and Healthcare.
- Henshaw Capital's largest Q3 2022 buy was Ferrari: 2,310 shares worth $427K.
- Henshaw Capital added most to Xometry in Q3 2022, an estimated $1.13M increase.
- Henshaw Capital's biggest Q3 2022 reduction was Carlisle Companies, cutting an estimated $882K.
- Henshaw Capital fully exited Sanofi in Q3 2022, selling an estimated $412K.
- Henshaw Capital's ten largest holdings make up 34% of its $1.35B portfolio in Q3 2022.
- Henshaw Capital opened 19 new positions and closed 26 in Q3 2022.
- Henshaw Capital's portfolio value fell 6.2% quarter-over-quarter to $1.35B.
Based on Henshaw Capital's 13F filing for Q3 2022, filed 28 May 2026.